BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28382553)

  • 1. Circulating periostin levels increase in association with bone density loss and healing progression during the early phase of hip fracture in Chinese older women.
    Yan J; Liu HJ; Li H; Chen L; Bian YQ; Zhao B; Han HX; Han SZ; Han LR; Wang DW; Yang XF
    Osteoporos Int; 2017 Aug; 28(8):2335-2341. PubMed ID: 28382553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Teriparatide Treatment on Circulating Periostin and Its Relationship to Regulators of Bone Formation and BMD in Postmenopausal Women With Osteoporosis.
    Gossiel F; Scott JR; Paggiosi MA; Naylor KE; McCloskey EV; Peel NFA; Walsh JS; Eastell R
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1302-1309. PubMed ID: 29365099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum carcinoembryonic antigen-related cell adhesion molecule 1 level in postmenopausal women: correlation with β-catenin and bone mineral density.
    Ma C; Shuai B; Shen L; Yang YP; Xu XJ; Li CG
    Osteoporos Int; 2016 Apr; 27(4):1529-1535. PubMed ID: 26572758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study.
    Garnero P; Sornay-Rendu E; Munoz F; Borel O; Chapurlat RD
    Osteoporos Int; 2013 Feb; 24(2):489-94. PubMed ID: 22525978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum parathyroid hormone is associated with increased cortical porosity of the inner transitional zone at the proximal femur in postmenopausal women: the Tromsø Study.
    Osima M; Borgen TT; Lukic M; Grimnes G; Joakimsen RM; Eriksen EF; Bjørnerem Å
    Osteoporos Int; 2018 Feb; 29(2):421-431. PubMed ID: 29134242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrosis markers, hip fracture risk, and bone density in older adults.
    Barzilay JI; Bůžková P; Kizer JR; Djoussé L; Ix JH; Fink HA; Siscovick DS; Cauley JA; Mukamal KJ
    Osteoporos Int; 2016 Feb; 27(2):815-20. PubMed ID: 26267013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating irisin is associated with osteoporotic fractures in postmenopausal women with low bone mass but is not affected by either teriparatide or denosumab treatment for 3 months.
    Anastasilakis AD; Polyzos SA; Makras P; Gkiomisi A; Bisbinas I; Katsarou A; Filippaios A; Mantzoros CS
    Osteoporos Int; 2014 May; 25(5):1633-42. PubMed ID: 24599275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which is the preferred site for bone mineral density monitoring as an indicator of treatment-related anti-fracture effect in routine clinical practice? A registry-based cohort study.
    Leslie WD; Martineau P; Bryanton M; Lix LM
    Osteoporos Int; 2019 Jul; 30(7):1445-1453. PubMed ID: 31016351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressed bone turnover was associated with increased osteoporotic fracture risks in non-obese postmenopausal Chinese women with type 2 diabetes mellitus.
    Jiajue R; Jiang Y; Wang O; Li M; Xing X; Cui L; Yin J; Xu L; Xia W
    Osteoporos Int; 2014 Aug; 25(8):1999-2005. PubMed ID: 24760246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of bone turnover markers to the variation in bone mineral density: a study in Vietnamese men and women.
    Nguyen LT; Nguyen UDT; Nguyen TDT; Ho-Pham LT; Nguyen TV
    Osteoporos Int; 2018 Dec; 29(12):2739-2744. PubMed ID: 30196375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
    Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
    Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxytocin and bone status in men: analysis of the MINOS cohort.
    Breuil V; Fontas E; Chapurlat R; Panaia-Ferrari P; Yahia HB; Faure S; Euller-Ziegler L; Amri EZ; Szulc P
    Osteoporos Int; 2015 Dec; 26(12):2877-82. PubMed ID: 26109496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Periostin Level is not a Predictor of Early Stage Bone Loss in Chinese Postmenopausal Women.
    Luo J; Deng W
    Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The levels of bone turnover markers in Chinese postmenopausal women: Peking Vertebral Fracture study.
    Zhao J; Xia W; Nie M; Zheng X; Wang Q; Wang X; Wang W; Ning Z; Huang W; Jiang Y; Li M; Wang O; Xing X; Sun Y; Luo L; He S; Yu W; Lin Q; Pei Y; Zhang F; Han Y; Tong Y; Che Y; Shen R; Hu Y; Zhou X; Xu L
    Menopause; 2011 Nov; 18(11):1237-43. PubMed ID: 21747303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein, bone loss, fracture, and mortality in elderly women: a longitudinal study in the OPRA cohort.
    Berglundh S; Malmgren L; Luthman H; McGuigan F; Åkesson K
    Osteoporos Int; 2015 Feb; 26(2):727-35. PubMed ID: 25410434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical markers of bone turnover and risk of incident hip fracture in older women: the Cardiovascular Health Study.
    Massera D; Xu S; Walker MD; Valderrábano RJ; Mukamal KJ; Ix JH; Siscovick DS; Tracy RP; Robbins JA; Biggs ML; Xue X; Kizer JR
    Osteoporos Int; 2019 Sep; 30(9):1755-1765. PubMed ID: 31227885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma periostin associates significantly with non-vertebral but not vertebral fractures in postmenopausal women: Clinical evidence for the different effects of periostin depending on the skeletal site.
    Kim BJ; Rhee Y; Kim CH; Baek KH; Min YK; Kim DY; Ahn SH; Kim H; Lee SH; Lee SY; Kang MI; Koh JM
    Bone; 2015 Dec; 81():435-441. PubMed ID: 26297442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMD T-score discriminates trochanteric fractures from unfractured controls, whereas geometry discriminates cervical fracture cases from unfractured controls of similar BMD.
    Pulkkinen P; Partanen J; Jalovaara P; Jämsä T
    Osteoporos Int; 2010 Jul; 21(7):1269-76. PubMed ID: 19784537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated DXA-based finite element analysis for hip fracture risk stratification: a cross-sectional study.
    Yang S; Leslie WD; Luo Y; Goertzen AL; Ahmed S; Ward LM; Delubac I; Lix LM
    Osteoporos Int; 2018 Jan; 29(1):191-200. PubMed ID: 29038836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low serum concentrations of Irisin are associated with increased risk of hip fracture in Chinese older women.
    Yan J; Liu HJ; Guo WC; Yang J
    Joint Bone Spine; 2018 May; 85(3):353-358. PubMed ID: 28408276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.